🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Florid

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Florid

22 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan Florid.

Vil nan Florid

Tèks ofisyèl etid la (Anglè)

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

  • Mayo Clinic in Florida, Jacksonville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06265285

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #48, Celebration
  • Exelixis Clinical Site #11, Gainesville
  • Exelixis Clinical Site #78, Jacksonville
  • ak 2 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

  • UF Health Cancer Institute - Gainesville, Gainesville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06524544

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

  • University of Florida Health Science Center, Gainesville
Ap rekrite
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06262516

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Holy Cross Hospital, Fort Lauderdale
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • University of Florida, Gainesville
  • Mount Sinai Medical Center of Florida, Inc., Miami
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • BRCR Global-Coral Springs, Coral Springs
  • Mayo Clinic Florida, Jacksonville
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
  • ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • MDR Core Network, Boynton Beach
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • AdventHealth Orlando, Orlando
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06439836

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

  • Research Site, Jacksonville
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07815665

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • University of Miami, Miami
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

  • University of Florida, Gainesville
Ap rekriteFaz 2
Laj 18 a 99 · Fanm · Mizajou Sep 9, 2026 · NCT06184516

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  • Bioresearch Partner - Aventura, Aventura
  • University of Florida Health (UF Health), Cancer Center, Gainesville
  • Bioresearch Partner - Hialeah Hospital, Hialeah
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06774131

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

  • Mayo Clinic in Florida, Jacksonville
Ap rekriteFaz 1/2
Laj 16 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05269381

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Clermont Oncology Center, Clermont
  • Mid Florida Hematology and Oncology Center, Orange City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • Florida Cancer Specialists, Bonita Springs
  • Florida Cancer Specialists, Bradenton
  • Florida Cancer Specialists, Bradenton
  • ak 14 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

  • Advanced Urology Institute - Daytona Beach, Daytona Beach
Ap rekrite
Laj 18 a 88 · Tout sèks · Mizajou Jul 2, 2026 · NCT06394869

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

  • Orlando Health, Orlando
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07484022

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

  • Dren Investigational Site, Orlando
  • Dren Investigational Site, Sarasota
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.